The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 5/7/2021 featuring funding details for BigBrain, Material Bank, and much more. This page will be updated throughout the day to reflect any new fundings.
BigBrain — $4.5M – Seed
BigBrain, the mobile trivia gaming app that offers cash prizes, has raised $4.5M in Seed funding from investors that include First Round Capital, BoxGroup, Ludlow Ventures, and Golden Ventures. BigBrain was founded by Nik Bonaddio in 2019.
Material Bank — $100M – Series C
Material Bank, the marketplace for searching and sampling architectural, design, and construction materials, has raised $100M in Series C funding from investors that include General Catalyst, Bain Capital Ventures, Lead Edge Capital, Raine Ventures, Durable Capital Partners, Bond, and Annox Capital. Founded by Adam Sandow in 2018, Material Bank has now raised a total of $148.2M in reported equity funding.
Glosslab — $4M – Seed Extension
Glosslab, the membership-based operator of nail studios, has raised $4M as a Seed extension from investors that include Michael Ryan Dubin, Patrick Schwarzenegger, Alex Pall, Amar’e Stoudemire, Mark Sanchez, Drew Taggart, Shmuel Gniwisch, Elias Davis, Jarrod Moses, Jim Huether, Marie Von Behrens, Louis Krubich, Wilton Speight, Dan Fried, Jared Goff, and Jeff Frommer. Founded by Rachel Apfel Glass in 2018, Glosslab has now raised a total of $7M+ in reported equity funding. AlleyWatch published an exclusive interview with Glass in December covering the initial seed funding – Glosslab Raises $3M+ for its Unlimited Membership-Based Nail Studios
Inspiren — $1.6M – funding according to a recent SEC filing
Inspiren, the patient care monitoring system for nursing that uses computer vision and automation, has raised $1.6M in funding according to a recent SEC filing. The filing indicates that the total offering is for $2M and that there were thirteen investors in this close. Founded by Michael Wang, Paul Coyne, Vincent Cocito in 2016, Inspiren has now raised a total of $5.1M in reported equity funding.
Gilgamesh Pharmaceuticals — $27M – Series A
Gilgamesh Pharmaceuticals, the biotechnology focused on using psychedelic-related medicines for treatment of mental health conditions, has raised $27M in Series A funding from investors that include Route 66 Ventures, Palo Alto Investors, Prime Movers Lab, Gron Ventures, Noetic Fund, and JLS Fund. Founded by Andrew Kruegel, Dalibor Sames, Jeff Witkin, Jonathan Sporn, Mike Cunningham in 2019, Gilgamesh Pharmaceuticals has now raised a total of $29.6M in reported equity funding.